Company intelligence / Profile preview
Theriva Biologics
Rockville, Maryland, USAtherivabio.com ↗
- Ownership
- Public · TOVX
- Employees
- ~21
- Development stage
- Phase 2
01
Overview
Theriva Biologics has demonstrated encouraging clinical evidence with its lead programs. Recent data from a Phase 1b/2a trial of SYN‑004 showed safety and pharmacokinetic results in allogeneic HCT recipients. The company’s lead asset VCN‑01 continues to advance in trials targeting solid tumors by breaking down the tumor stroma barrier to enhance anti-tumor effects. Additional preclinical work includes next-generation oncolytic virus candidates using proprietary technologies.
- Therapeutic areas
- OncologyImmunologyGastroenterology
- Modalities
- Oncolytic viruses (adenovirus platform)Recombinant enzymes
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Request access →03
Partnerships
Not explicitly listed; collaborations likely with academic institutions such as Washington University School of Medicine involved in clinical trials
04
Financials
- Market cap
- $4.6M
- Total revenue
- $0
- Enterprise value
- $-4.1M
Beyond the preview
Go deeper on Theriva Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theriva Biologics.